Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Family Physician
M.B.B.S, M.C.P.S (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Endocrinologist
MBBS, MRCP (Diabetes & Endocrinology), CCT (Endocrinology & Diabetes), CCT General Internal Medicine, FRCP
Endocrinologist
MBBS, MRCP (Diabetes & Endocrinology), CCT (Endocrinology & Diabetes), CCT General Internal Medicine, FRCP
General Physician
MBBS, MRCP Diabetes and Endocrinology (RCP London), MRCP Internal Medicine (RCP London), CCT (UK)
General Physician
MBBS, MRCP Diabetes and Endocrinology (RCP London), MRCP Internal Medicine (RCP London), CCT (UK)
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship in Diabetes & Endocrine
Internal Medicine Specialist
MBBS, MD (Internal Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures